Published within
| Type |
Product title / description
|
Pub
|
Price |
Report
|
The report provides an overview of biosimilar and copy-biologic product landscape, split by marketed and pipeline products, target therapy areas and indications, geography, and drug developers.
Published By Datamonitor
|
09 Dec 2011 |
$5700
|
Report
|
CNS drugs are associated with longer development times and higher attrition rates than drugs for other therapy areas. Advances in delivery technologies are essential if the pursuit of novel CNS treatments is to remain commercially viable.
Published By Datamonitor
|
05 Sep 2012 |
$3800
|
Report
|
CNS drugs are associated with longer development times and higher attrition rates than drugs for other therapy areas. Advances in delivery technologies are essential if the pursuit of novel treatments is to remain commercially viable.
Published By Datamonitor
|
05 Sep 2012 |
$3800
|
Report
|
Favorable legislation and recent commercial successes have stimulated growing interest in the discovery of novel orphan drugs. However, there are many strategic considerations that are peculiar to the R&D process for diseases of low prevalence.
Published By Datamonitor
|
31 Aug 2012 |
$3800
|
Report
|
An overview of the healthcare reforms undertaken in Saudi Arabia and insights into the future of the healthcare industry, including evolving patient demographics, pricing and reimbursement, and development of pharma companies in the Kingdom.
Published By Datamonitor
|
01 Jun 2009 |
$5700
|
Report
|
An update of the latest regulatory healthcare reforms in Abu Dhabi and Dubai, with analysis of the impact of these changes on key stakeholders in the healthcare sector, plus reviews the latest commercial trends adopted in the industry.
Published By Datamonitor
|
07 Jan 2010 |
$3800
|
Report
|
This report provides an analysis of strategies and trends employed by companies operating in the in vitro diagnostics (IVDs) market in order to drive revenue growth.
Published By Datamonitor
|
17 Jul 2012 |
$3800
|
Report
|
This content analyzes indication expansion as a brand lifecycle management strategy, including key success drivers and resistors and case studies of both successful and unsuccessful examples of indication expansions.
Published By Datamonitor
|
22 Nov 2012 |
$1900
|
Report
|
This report analyzes pharma-payer deals as a brand lifecycle management strategy and includes an overview of the strategy with key success drivers and resistors and successful and unsuccessful case studies of such deals.
Published By Datamonitor
|
16 Aug 2012 |
$1900
|
Report
|
This report analyzes reformulation as a brand lifecycle management strategy and includes an overview of the strategy with key success drivers and resistors and successful and unsuccessful case studies of reformulated brands.
Published By Datamonitor
|
24 Jul 2012 |
$1900
|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.